North America Cancer Stem Cells Market Size & Outlook
The cancer stem cells market in North America is expected to reach a projected revenue of US$ 1.0 million by 2030. A compound annual growth rate of -59.9% is expected of North America cancer stem cells market from 2024 to 2030.
Revenue, 2023 (US$M)
$603.4
Forecast, 2030 (US$M)
$1.0
CAGR, 2024 - 2030
-59.9%
Report Coverage
North America
North America cancer stem cells market, 2018-2030 (US$M)
North America cancer stem cells market highlights
- The North America cancer stem cells market generated a revenue of USD 603.4 million in 2023.
- The market is expected to grow at a CAGR of -59.9% from 2024 to 2030.
- In terms of segment, breast cancer was the largest revenue generating cancer type in 2023.
- Breast Cancer is the most lucrative cancer type segment registering the fastest growth during the forecast period.
North America data book summary
| Market revenue in 2023 | USD 603.4 million |
| Market revenue in 2030 | USD 1.0 million |
| Growth rate | -59.9% (CAGR from 2023 to 2030) |
| Largest segment | Breast cancer |
| Fastest growing segment | Breast Cancer |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Breast Cancer |
| Key market players worldwide | Thermo Fisher Scientific Inc, AbbVie Inc, Merck KGaA, Lonza Group Ltd, Bionomics Ltd ADR, Menarini Group, Miltenyi Biotec, PromoCell GmbH, Macrogenics Inc, FUJIFILM Holdings Corp, Stemcell Holdings Inc Ordinary Shares, Sino Biological, Lineage Logistics, Mereo BioPharma Group PLC ADR |
Other key industry trends
- In terms of revenue, North America region accounted for 43.3% of the global cancer stem cells market in 2023.
- Globally, Europe is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 677.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cancer Stem Cells Market Scope
Cancer stem cells market segmentation & scope
Breast Cancer
Blood Cancer
Lung Cancer
Brain Cancer
Colorectal Cancer
Pancreatic Cancer
Bladder Cancer
Liver Cancer
Others
Countries
U.S.
Canada
Germany
France
Italy
Spain
Switzerland
Netherlands
Denmark
Sweden
Norway
Japan
China
India
Australia
South Korea
Indonesia
Thailand
Mexico
Brazil
South Africa
Saudi Arabia
UK
Argentina
UAE
Kuwait
Cancer Stem Cells Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America cancer stem cells market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cancer stem cells market will help companies and investors design strategic landscapes.
Breast cancer was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the North America cancer stem cells market based on breast cancer covering the revenue growth of each sub-segment from 2018 to 2030.
- North America Cancer Stem Cells Cancer Type Outlook (Revenue, USD Million, 2018-2030)
- Breast Cancer
- Blood Cancer
- Lung Cancer
- Brain Cancer
- Colorectal Cancer
- Pancreatic Cancer
- Bladder Cancer
- Liver Cancer
- Others
Reasons to subscribe to North America cancer stem cells market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America cancer stem cells market databook
-
Our clientele includes a mix of cancer stem cells market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America cancer stem cells market , including forecasts for subscribers. This continent databook contains high-level insights into North America cancer stem cells market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America cancer stem cells market
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
